Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 9, No. 3
March 2003

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Comments | Email this article Email this article


Experimental Infection of North American Birds with the New York 1999 Strain of West Nile Virus

Nicholas Komar,* Stanley Langevin,* Steven Hinten,* Nicole Nemeth,*† Eric Edwards,*† Danielle Hettler,*† Brent Davis,* Richard Bowen,† and Michel Bunning*‡
*Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; †Colorado State University, Fort Collins, Colorado, USA; and ‡Office of the Surgeon General, United States Air Force, Bolling Air Force Base, Washington, D.C., USA

Appendix C (online only)

Plaque Assay

Plaque assay for detecting and titrating infectious WNV particles in blood samples, cloacal and oral swabs, and organ tissues was carried out by using a double overlay system in Vero (a continuous line of African Green Monkey kidney cells) culture. Most blood specimens were titrated after a single freeze-thaw cycle. Organ samples were titrated after one or two freeze-thaw cycles. Some high-titered specimens were titrated by using serial 10-fold dilutions in BA1 after an additional freeze-thaw. After inoculating cell monolayers with 0.1 mL (in duplicate) and incubating the sample for 1 h at 37°C, 5% CO2, each well was overlaid with 3 mL of 0.5% agarose in M-199 medium supplemented with 350 mg/L sodium bicarbonate, 29.2 mg/L L-glutamine, and antibiotics as in BA1. After 48 h of additional incubation, a second 3-mL 0.5% agarose overlay containing 0.004 % neutral red dye was added for plaque visualization. Plaques were counted on days 3 and 4 after infection of the Vero cells.

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Nicholas Komar, Centers for Disease Control and Prevention, P.O. Box 2087, Fort Collins, CO 80522, USA; fax: 970-221-6476; email: nck6@cdc.gov

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted January 30, 2003
This page last reviewed January 5, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention